Cryopreservation-related loss of antigen-specific IFNγ producing CD4+ T-cells can skew immunogenicity data in vaccine trials: Lessons from a malaria vaccine trial substudy

[1]  S. Néron,et al.  A global look into human T cell subsets before and after cryopreservation using multiparametric flow cytometry and two-dimensional visualization analysis. , 2016, Journal of immunological methods.

[2]  A. Hill,et al.  Progress with viral vectored malaria vaccines: A multi-stage approach involving “unnatural immunity” , 2015, Vaccine.

[3]  Joshua M. Obiero,et al.  Early Effector Cells Survive the Contraction Phase in Malaria Infection and Generate Both Central and Effector Memory T Cells , 2015, The Journal of Immunology.

[4]  G. Leroux-Roels,et al.  Processing of blood samples influences PBMC viability and outcome of cell-mediated immune responses in antiretroviral therapy-naïve HIV-1-infected patients. , 2014, Journal of immunological methods.

[5]  R. Cortese,et al.  Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations. , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

[6]  Bjoern Peters,et al.  Sterile Immunity to Malaria after DNA Prime/Adenovirus Boost Immunization Is Associated with Effector Memory CD8+T Cells Targeting AMA1 Class I Epitopes , 2014, PloS one.

[7]  M. McElrath,et al.  Optimization of a whole blood phenotyping assay for enumeration of peripheral blood leukocyte populations in multicenter clinical trials. , 2014, Journal of immunological methods.

[8]  Guido Ferrari,et al.  The Center for HIV/AIDS Vaccine Immunology (CHAVI) multi-site quality assurance program for cryopreserved human peripheral blood mononuclear cells. , 2014, Journal of immunological methods.

[9]  M. McElrath,et al.  Benefits of a comprehensive quality program for cryopreserved PBMC covering 28 clinical trials sites utilizing an integrated, analytical web-based portal. , 2014, Journal of immunological methods.

[10]  N. Frahm,et al.  Establishment and maintenance of a PBMC repository for functional cellular studies in support of clinical vaccine trials. , 2014, Journal of immunological methods.

[11]  D. Kelly,et al.  Effect of cryopreservation of peripheral blood mononuclear cells (PBMCs) on the variability of an antigen-specific memory B cell ELISpot , 2014, Human vaccines & immunotherapeutics.

[12]  Lucy Dorrell,et al.  Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1. , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

[13]  A. Folgori,et al.  Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation , 2013, Nature Communications.

[14]  R. Stephens,et al.  Early Decision: Effector and Effector Memory T Cell Differentiation in Chronic Infection , 2013, Current immunology reviews.

[15]  T. Hertz,et al.  HIV-1 Vaccine-Induced T-Cell Reponses Cluster in Epitope Hotspots that Differ from Those Induced in Natural Infection with HIV-1 , 2013, PLoS pathogens.

[16]  J. Margolick,et al.  Value of a Quality Assessment Program in Optimizing Cryopreservation of Peripheral Blood Mononuclear Cells in a Multicenter Study , 2013, Clinical and Vaccine Immunology.

[17]  D. Watkins,et al.  A trivalent recombinant Ad5 gag/pol/nef vaccine fails to protect rhesus macaques from infection or control virus replication after a limiting-dose heterologous SIV challenge. , 2012, Vaccine.

[18]  R. Longley,et al.  Mixed Vector Immunization With Recombinant Adenovirus and MVA Can Improve Vaccine Efficacy While Decreasing Antivector Immunity , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[19]  A. Kamali,et al.  Setting Up a Standardized Peripheral Blood Mononuclear Cells Processing Laboratory to Support Multi-center HIV/AIDS Vaccine and Intervention Trials , 2011 .

[20]  A. Hill,et al.  CD8+ T Effector Memory Cells Protect against Liver-Stage Malaria , 2011, The Journal of Immunology.

[21]  Mario Roederer,et al.  SPICE: Exploration and analysis of post‐cytometric complex multivariate datasets , 2011, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[22]  S. Self,et al.  Equivalence of ELISpot Assays Demonstrated between Major HIV Network Laboratories , 2010, PloS one.

[23]  R. Koup,et al.  Safety and Immunogenicity Study of Multiclade HIV-1 Adenoviral Vector Vaccine Alone or as Boost following a Multiclade HIV-1 DNA Vaccine in Africa , 2010, PloS one.

[24]  J. Ahlers,et al.  Memories that last forever: strategies for optimizing vaccine T-cell memory. , 2010, Blood.

[25]  Marcella Sarzotti-Kelsoe,et al.  Evaluation and Recommendations on Good Clinical Laboratory Practice Guidelines for Phase I–III Clinical Trials , 2009, PLoS medicine.

[26]  P. Kaleebu,et al.  Concordant Proficiency in Measurement of T-Cell Immunity in Human Immunodeficiency Virus Vaccine Clinical Trials by Peripheral Blood Mononuclear Cell and Enzyme-Linked Immunospot Assays in Laboratories from Three Continents , 2008, Clinical and Vaccine Immunology.

[27]  Rachel E. Owen,et al.  Loss of T cell responses following long-term cryopreservation. , 2007, Journal of immunological methods.

[28]  M. McElrath,et al.  Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials. , 2007, Journal of immunological methods.

[29]  M. Caulfield,et al.  Establishing Acceptance Criteria for Cell-Mediated-Immunity Assays Using Frozen Peripheral Blood Mononuclear Cells Stored under Optimal and Suboptimal Conditions , 2007, Clinical and Vaccine Immunology.

[30]  K. Foulds,et al.  Th1 memory: implications for vaccine development , 2006, Immunological reviews.

[31]  G. Silvestri,et al.  Effects of cryopreservation on lymphocyte immunophenotype and function. , 2003, Journal of immunological methods.

[32]  B. Boehm,et al.  CD4+ and CD8+ cells in cryopreserved human PBMC maintain full functionality in cytokine ELISPOT assays. , 2003, Journal of immunological methods.

[33]  M. Hudgens,et al.  Moving to human immunodeficiency virus type 1 vaccine efficacy trials: defining T cell responses as potential correlates of immunity. , 2003, The Journal of infectious diseases.

[34]  M. Venkataraman.  Effects of cryopreservation on immune responses. VIII. Enhanced secretion of interferon-gamma by frozen human peripheral blood mononuclear cells. , 1995, Cryobiology.